Emergent BioSolutions Inc. provided revenue guidance for the second quarter of 2024. For the quarter, the company reported total revenue of $160 million to $210 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.49 USD | +6.09% |
|
+8.71% | +212.08% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+212.08% | 370M | |
+55.55% | 823B | |
+42.31% | 641B | |
-6.83% | 352B | |
+17.15% | 324B | |
+7.09% | 301B | |
+14.02% | 241B | |
+1.64% | 223B | |
+13.66% | 218B | |
+7.87% | 167B |
- Stock Market
- Equities
- EBS Stock
- News Emergent BioSolutions Inc.
- Emergent BioSolutions Inc. Provides Revenue Guidance for the Second Quarter of 2024